BioCatalyst

Mirvetuximab soravtansine, Carboplatin — catalyst calendar

1 verified catalyst event(s) referencing Mirvetuximab soravtansine, Carboplatin, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 3mo
ESTIMATED
 READOUT
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Fo
Phase 2 · High Grade Ovarian Cancer, Primary Peritoneal Cancer
 ABBV AbbVie Inc. Mirvetuximab soravtansine, Carboplatin ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.